NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer prot...
Leadership
Michael Harvey Davidson FACC, Facp., M.D.
CEO, President & Executive Director
Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.Founder
Founder, Chief Scientific Officer, Member of Executive Board & Director
Mayur Amrat Somaiya
Chief Financial Officer
Douglas F. Kling
Chief Operating Officer
Louise Kooij
Chief Accounting Officer
Matthew Philippe
Executive VP & Head of Investor Relations
Michael F. Marino Esq.
Chief Legal Officer & Corporate Secretary
Chris Deluzio
Executive Vice President of Sales Enterprise Operations
